62-year-old Navi Mumbai resident regains sight after rare dual eye surgery at Dr Agarwals Eye Hospital

• Patient’s vision improves significantly after combined cataract surgery and Pinhole Pupilloplasty for mature cataract with dense corneal scar • Pinhole Pupilloplasty, pioneered by Dr. Amar Agarwal, has helped reduce …

62-year-old Navi Mumbai resident regains sight after rare dual eye surgery at Dr Agarwals Eye Hospital Read More

डॉ अग्रवालस् आय हॉस्पिटल मध्ये दुर्मिळ अशा दुहेरी नेत्र शस्त्रक्रियेनंतर नवी मुंबईतील 62 वर्षीय व्यक्तीला दृष्टिदान.

• खोल कॉर्नियल स्कार असलेल्या परिपक्व मोतीबिंदूवर मोतीबिंदू शस्त्रक्रिया आणि पिनहोल प्युपिलोप्लास्टी या एकत्रित उपचारानंतर रुग्णाच्या दृष्टीमध्ये लक्षणीय सुधारणा झाली आहे. • डॉ. अमर अग्रवाल यांनी विकसित केलेल्या पिनहोल प्युपिलोप्लास्टीमुळे, …

डॉ अग्रवालस् आय हॉस्पिटल मध्ये दुर्मिळ अशा दुहेरी नेत्र शस्त्रक्रियेनंतर नवी मुंबईतील 62 वर्षीय व्यक्तीला दृष्टिदान. Read More

Bank of India Officers’ Association Organises Health Check-up Camp at BOI Head Office

Bank of India Officers’ Association Organises Health Check-up Camp at BOI Head Office Mumbai 15 th July 2026 ( TGN ) : Commemorating the upcoming 57th Bank Nationalisation Day and …

Bank of India Officers’ Association Organises Health Check-up Camp at BOI Head Office Read More

Tryfacta, Inc. Awarded National Institutes of Health (NIH) Healthcare Staffing Contract

Award Reinforces Tryfacta’sCommitment to Delivering Mission-Critical Clinical Staffing for the Nation’s Premier Federal Health Institution. June 17, 2026  ( TGN )– Tryfacta, Inc., an artificial intelligence (“AI”)-enabled provider of specialized …

Tryfacta, Inc. Awarded National Institutes of Health (NIH) Healthcare Staffing Contract Read More

India’s First CAR T-Cell Therapy Shows Durable Results: Two-Year Remission Achieved in Blood Cancer Patients

India’s First CAR T-Cell Therapy Shows Durable Results: Two-Year Remission Achieved in Blood Cancer Patients Breakthrough data from Immuneel Therapeutics shows sustained remission in multiple patients treated with Varnimcabtagene autoleucel …

India’s First CAR T-Cell Therapy Shows Durable Results: Two-Year Remission Achieved in Blood Cancer Patients Read More